Evidence map›Paper›PMID 39649581›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Multivariate genetic of 2.2 million individuals demonstrate genetic influences on substance use disorders operate via behavioral disinhibition and substance-specific risk.

Holly E Poore, Chris Chatzinakos, Brittany Leger, Jean Gonzalez, Travis T Mallard, Sandra Sanchez-Roige, Fazil Aliev, Alexander Hatoum, COGA Collaborators, Irwin D Waldman and 4 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Holly E PooreDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University.
Chris ChatzinakosDepartment of Psychiatry and Behavioral Science, SUNY Downstate Health Sciences University.
Brittany LegerDepartment of Psychiatry, University of California San Diego.
Jean GonzalezDepartment of Psychiatry, University of California San Diego.
Travis T MallardCenter for Precision Psychiatry, Department of Psychiatry, Massachusetts General Hospital.
Sandra Sanchez-RoigeDepartment of Psychiatry, University of California San Diego.
Fazil AlievDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University.
Alexander HatoumDepartment of Psychiatry, Washington University School of Medicine.
COGA Collaborators
Irwin D WaldmanDepartment of Psychology, Emory University.
Abraham A PalmerDepartment of Psychiatry, University of California San Diego.ORCID 0000-0003-3634-0747
K Paige HardenDepartment of Psychology, University of Texas at Austin.
Danielle M DickDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University.
Peter B BarrDepartment of Psychiatry and Behavioral Science, SUNY Downstate Health Sciences University.ORCID 0000-0001-9321-657X

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI JAY Arnold TISCHFIELD · 1989 to 2026
$162.7M
Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studiesP50AA022537 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI JENNIFER T WOLSTENHOLME · 2014 to 2026
$19.6M
Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
The development of alcohol misuse and related problems from adolescence to early midlifeR01AA015416 · NIAAA · WASHINGTON UNIVERSITY · PI DICK, DANIELLE M, SALVATORE, JESSICA E · 2005 to 2024
$7.6M
Using the Genetic Architecture of Substance Use Disorders to Advance Gene Identification and Understanding of Pathways of RiskR01DA050721 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIELLE M DICK · 2020 to 2026
$3.9M
UC San Diego Genetics Training ProgramT32GM145427 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRUCE A HAMILTON · 2022 to 2026
$2.6M
Building Bridges to Allow Cross-species Translational genetics for the Study of AddictionDP1DA054394 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SANCHEZ ROIGE, SANDRA · 2021 to 2025
$2.4M
Molecular Neuroscience of Alcohol and Drug Abuse Research TrainingT32AA028254 · NIAAA · RUTGERS, THE STATE UNIV OF N.J. · PI ASTON-JONES, GARY S., SARKAR, DIPAK KUMAR · 2019 to 2023
$1.3M
Twin, molecular, and developmental approaches to understanding alcohol misuseK02AA018755 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DICK, DANIELLE M · 2010 to 2019
$1.3M
Understanding developmental neurogenomic mechanisms in externalizing disordersK08MH135343 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI Travis T Mallard · 2024 to 2026
$588k
Exploring the Interface between Substance Use Disorders and other Forms of Psychopathology using Phenotypic and Genomic ApproachesK01DA059657 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Holly Poore · 2025 to 2026
$310k
NIAAA NIH HHS K02 AA018755NIAAA NIH HHS P50 AA022537NIAAA NIH HHS R01 AA015416NIAAA NIH HHS T32 AA028254NIAAA NIH HHS U10 AA008401NIDA NIH HHS DP1 DA054394NIDA NIH HHS K01 DA059657NIDA NIH HHS R01 DA050721NIGMS NIH HHS T32 GM008666NIGMS NIH HHS T32 GM145427NIMH NIH HHS K08 MH135343
6 · The paper itself

Abstract

Ongoing efforts to identify genes involved in substance use disorders (SUDs) often focus on individual disorders despite high rates of co-occurrence with each other and other externalizing traits. Here, we investigate whether incorporating data on other externalizing traits can boost power to detect without sacrificing specificity of SUD genetic signal. We used multivariate genomic analyses and downstream biological annotation and genetic association analyses to explore this question. We found that joint analysis of SUDs and other externalizing traits resulted in increased insights into the neurobiology of broad and substance-specific SUD risk. We found no evidence of loss of specificity for SUD genetic signal but note improvements in our ability to characterize the neurobiology of broad and substance-specific SUD genetic effects. Our findings suggest that genetic risk for SUDs operates largely via pathways shared with other behaviors characterized by behavioral disinhibition, with additional substance-specific risk, and that modeling this shared disposition improves gene discovery.

Identifiers

PMID39649581
PMCPMC11623735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.